Worried About the Stock Market in 2026? These 3 Stocks Did Well During the Last Bear Market.

Core Viewpoint - Concerns about potential market downturns in 2025 are prompting investors to consider safer investment options, particularly in blue chip stocks with strong fundamentals [1][2]. Group 1: Investment Strategies - Investors are advised to protect their portfolios by focusing on blue chip stocks that have good fundamentals and are likely to be resilient during market downturns [2]. - Diversifying investments into sectors that may perform better in a downturn is recommended [2]. Group 2: Company Analysis - AbbVie - AbbVie shares rose by 19% during the S&P 500 crash of over 19% in 2022, demonstrating stability and growth with a 3% increase in revenue and a profit margin exceeding 20% [5]. - The company is successfully replacing revenue lost from its top-selling drug Humira with new immunology drugs Skyrizi and Rinvoq, showcasing its innovation capabilities [6]. - AbbVie operates in multiple segments including oncology, aesthetics, and neuroscience, providing various growth avenues [7]. - The stock trades at 16 times estimated future earnings and offers a dividend yield of 3.1%, significantly higher than the S&P 500 average of 1.1%, making it a solid long-term investment [8]. Group 3: Company Analysis - Eli Lilly - Eli Lilly's shares increased by 32% in 2022, significantly outperforming the market, driven by the success of its GLP-1 drugs, Mounjaro for diabetes and Zepbound for weight loss [11].